Aims: To compare care recipient and caregiver perceptions of quality of life in patients (QoLp) with Alzheimer's disease (AD). To identify associated factors, and the concordancesdiscrepancies.
Method:Cross-sectional analytic study of 236 patients and their carers using the Quality of Life in Alzheimer's Disease (QoL-AD) scale, socio-demographic data and clinical examination.
Results:Patients scored the QoL-AD more favourably than did caregivers (34.4 vs. 31.3, p<0.001). Cognitive deterioration did not affect the perception of QoL-AD (rho= -0.05, p=0.394). The neuropsychiatric symptoms was associated with a negative perception of the QOL-AD in both patients (rho= -0.22, p<0.01) and caregivers (rho= -0.47, p <0.001). Greater functional autonomy was associated with a better perception of the QOL-AD in patients (rho= 0.17, p<0.01) and even more so in caregivers (rho= 0.56, p<0.001). In carers, burden (rho= -0.56, p<0.001) and mental health (rho= 0.31, p<0.001) were inversely associated with the QoL-AD. QoL-AD scores of both patients and caregivers were higher for men, married subjects, those who lived with their spouse and those living in their own home. When the carer was a spouse both patients and caregivers scored the QoL-AD higher than when the carer was a son or daughter (35.5 vs. 33.4 and 33.7; 32.9 vs. 30.5 and 27.7, p<0,001).
Conclusions
The incidence of EOD was less than 6 cases per 100,000 person-years in the age group 30-49 years; in the age group 50-64 years, the incidence rate was 3-fold higher and doubled with each 5-year increase.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.